KEMPNER CAPITAL MANAGEMENT INC. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
KEMPNER CAPITAL MANAGEMENT INC. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$36,000
-23.4%
25,4750.0%0.02%
-26.7%
Q2 2023$47,000
-24.2%
25,4750.0%0.03%
-16.7%
Q1 2023$62,000
+70.2%
25,4750.0%0.04%
+63.6%
Q4 2022$36,429
-36.1%
25,4750.0%0.02%
-42.1%
Q3 2022$57,000
+7.5%
25,4750.0%0.04%
+18.8%
Q2 2022$53,000
-28.4%
25,4750.0%0.03%
-22.0%
Q1 2022$74,000
-9.8%
25,4750.0%0.04%
-14.6%
Q4 2021$82,000
-8.9%
25,4750.0%0.05%
-5.9%
Q3 2021$90,000
+11.1%
25,4750.0%0.05%
+10.9%
Q2 2021$81,000
-75.3%
25,475
-73.3%
0.05%
-75.7%
Q1 2021$328,000
+36.1%
95,4760.0%0.19%
+18.9%
Q4 2020$241,000
+19.9%
95,4760.0%0.16%
-1.2%
Q3 2020$201,000
-6.1%
95,4760.0%0.16%
-4.2%
Q2 2020$214,000
-11.6%
95,4760.0%0.17%
-20.4%
Q1 2020$242,000
-3.6%
95,4760.0%0.21%
+30.2%
Q4 2019$251,000
-27.0%
95,4760.0%0.16%
-30.5%
Q3 2019$344,000
+6.8%
95,4760.0%0.23%
+10.4%
Q2 2019$322,000
+23.4%
95,4760.0%0.21%
+22.7%
Q1 2019$261,000
-1.5%
95,4760.0%0.17%
-5.5%
Q4 2018$265,000
-32.6%
95,4760.0%0.18%
-27.8%
Q3 2018$393,000
-20.8%
95,4760.0%0.25%
-22.7%
Q2 2018$496,000
-5.2%
95,4760.0%0.33%
-8.4%
Q1 2018$523,000
-32.8%
95,4760.0%0.36%
-26.7%
Q4 2017$778,000
-22.2%
95,4760.0%0.49%
-26.1%
Q3 2017$1,000,000
-5.1%
95,4760.0%0.66%
-5.2%
Q2 2017$1,054,000
+31.9%
95,4760.0%0.69%
+30.5%
Q1 2017$799,000
+64.4%
95,476
+36.4%
0.53%
+50.7%
Q4 2016$486,000
+36.5%
70,0010.0%0.35%
+44.1%
Q3 2016$356,000
-14.8%
70,0010.0%0.24%
-8.6%
Q2 2016$418,000
+31.0%
70,0010.0%0.27%
+39.6%
Q1 2016$319,000
+1.3%
70,0010.0%0.19%
+3.8%
Q4 2015$315,000
+41.9%
70,0010.0%0.18%
+46.8%
Q3 2015$222,000
+4.7%
70,0010.0%0.13%
+14.5%
Q2 2015$212,000
+2.4%
70,0010.0%0.11%
-16.0%
Q1 2015$207,000
-33.4%
70,0010.0%0.13%
-6.4%
Q4 2014$311,000
-13.9%
70,0010.0%0.14%
-9.1%
Q3 2014$361,000
-1.9%
70,0010.0%0.15%
+5.5%
Q2 2014$368,000
+26.5%
70,0010.0%0.15%
+23.7%
Q1 2014$291,000
+42.6%
70,0010.0%0.12%
+35.6%
Q4 2013$204,000
+15.9%
70,0010.0%0.09%
+22.5%
Q3 2013$176,000
+20.5%
70,0010.0%0.07%
+16.4%
Q2 2013$146,00070,0010.06%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2023
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 3,312,792$22,991,0004.49%
First Light Asset Management, LLC 1,007,357$6,991,0003.07%
KOPP INVESTMENT ADVISORS LLC 211,974$1,471,0001.55%
GLOBEFLEX CAPITAL L P 223,931$1,554,0000.39%
Nine Chapters Capital Management LLC 30,900$214,0000.36%
KEMPNER CAPITAL MANAGEMENT INC. 70,001$486,0000.35%
Campbell & CO Investment Adviser LLC 11,513$80,0000.25%
EAM Investors, LLC 259,914$1,804,0000.24%
Teza Capital Management LLC 14,636$102,0000.14%
Acrospire Investment Management LLC 46,220$321,0000.13%
View complete list of ENZO BIOCHEM INC shareholders